Retracted: Inhibiting the PI3K/Akt, NF-κB signalling pathways with syringic acid for attenuating the development of oral squamous cell carcinoma cells SCC131

Periyannan Velu, Annamalai Vijayalakshmi, Veerasamy Vinothkumar

Open source

DOI
10.1111/jphp.13350
Published
2020-11-01
Container
Journal of Pharmacy and Pharmacology
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/jphp.13350,
  title = {Retracted: Inhibiting the PI3K/Akt, NF-κB signalling pathways with syringic acid for attenuating the development of oral squamous cell carcinoma cells SCC131},
  author = {Periyannan Velu and Annamalai Vijayalakshmi and Veerasamy Vinothkumar},
  year = {2020},
  journal = {Journal of Pharmacy and Pharmacology},
  doi = {10.1111/jphp.13350},
  url = {https://doi.org/10.1111/jphp.13350}
}

RIS

TY  - JOUR
TI  - Retracted: Inhibiting the PI3K/Akt, NF-κB signalling pathways with syringic acid for attenuating the development of oral squamous cell carcinoma cells SCC131
AU  - Periyannan Velu
AU  - Annamalai Vijayalakshmi
AU  - Veerasamy Vinothkumar
PY  - 2020
JO  - Journal of Pharmacy and Pharmacology
DO  - 10.1111/jphp.13350
UR  - https://doi.org/10.1111/jphp.13350
ER  - 

APA

Velu, P., Vijayalakshmi, A., & Vinothkumar, V. (2020). Retracted: Inhibiting the PI3K/Akt, NF-κB signalling pathways with syringic acid for attenuating the development of oral squamous cell carcinoma cells SCC131. Journal of Pharmacy and Pharmacology. https://doi.org/10.1111/jphp.13350

Source records